Not applicableUnknownNCT03178721What this trial is testingRegulatory BCells in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Assiut University 40
Testing effectiveness (Phase 2)Study completedNCT02847598What this trial is testingStudy to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus ErythematosusActive Cutaneous Lupus Erythematosus Biogen 264
Not applicableStudy completedNCT02281513What this trial is testingActivity and Nutrition Trial in Lupus to Energize and RenewWho this might be right forSystemic Lupus ErythematosusPhysical ActivitySleep Northwestern University 12
Testing effectiveness (Phase 2)Study completedNCT02437890What this trial is testingA Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus ErythematosusWho this might be right forLupus Erythematosus, Systemic Ablynx, a Sanofi company 312
Large-scale testing (Phase 3)Ended earlyNCT00539838What this trial is testingEvaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)Who this might be right forSystemic Lupus Erythematosus Genentech, Inc. 33
Testing effectiveness (Phase 2)Ended earlyNCT05540665What this trial is testingStudy of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)Who this might be right forLupus Nephritis Amgen 19
Post-approval studies (Phase 4)UnknownNCT02270970What this trial is testingEvaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding PolypharmacyWho this might be right forSystemic Lupus Erythematosus Oklahoma Medical Research Foundation 20
Large-scale testing (Phase 3)Ended earlyNCT03517722What this trial is testingUstekinumab in Participants With Active Systemic Lupus ErythematosusWho this might be right forLupus Erythematosus, Systemic Janssen Research & Development, LLC 516
Testing effectiveness (Phase 2)Looking for participantsNCT07053800What this trial is testingObe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)Who this might be right forLupus Nephritis Autolus Limited 35
Large-scale testing (Phase 3)Study completedNCT03312907What this trial is testingEvaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVEWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 292
Large-scale testing (Phase 3)Study completedNCT04294667What this trial is testingEvaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus UCB Biopharma SRL 321
Large-scale testing (Phase 3)Active Not RecruitingNCT05843643What this trial is testingProgram to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus AbbVie 1,014
Not applicableStudy completedNCT03537638What this trial is testingMulticomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLEWho this might be right forSystemic Lupus Erythematosus Servicio Canario de Salud 237
Testing effectiveness (Phase 2)Active Not RecruitingNCT07015983What this trial is testingCC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)Who this might be right forLupus Erythematosus, SystemicLupus Nephritis Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89
Not applicableLooking for participantsNCT06631404What this trial is testingRenal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis PatientsWho this might be right forLupus Nephritis Sohag University 55
Early research (Phase 1)Looking for participantsNCT06576271What this trial is testingGSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD ParticipantsWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 142
Not applicableStudy completedNCT05289544What this trial is testingPhone-Based Based Walk With Ease Program for Adults With ArthritisWho this might be right forArthritisGoutFibromyalgia+3 more University of South Carolina 267
Large-scale testing (Phase 3)Active Not RecruitingNCT04895241What this trial is testingLearn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusWho this might be right forLupus Erythematosus, Systemic Biogen 548
Not applicableStudy completedNCT01731054What this trial is testingFunctional MRI in Lupus NephritisWho this might be right forHealthyLupus Nephritis Biogen 50
Not applicableStudy completedNCT01772069What this trial is testingHealth-Related Quality of Life in Patients With Systemic Lupus Erythematosus:Focusing on FibromyalgiaWho this might be right forQuality of Life The Catholic University of Korea 300